Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Convalescent Plasma Therapy for COVID-19: State of the Art
Daniele Focosi, Arthur O. Anderson, Julian W. Tang, et al.
Clinical Microbiology Reviews (2020) Vol. 33, Iss. 4
Open Access | Times Cited: 126

Showing 1-25 of 126 citing articles:

Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19
Rohitash Yadav, Jitendra Kumar Chaudhary, Neeraj Jain, et al.
Cells (2021) Vol. 10, Iss. 4, pp. 821-821
Open Access | Times Cited: 389
Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline
Marco Tuccori, Sara Ferraro, Irma Convertino, et al.
mAbs (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 152
Review: Roles of human serum albumin in prediction, diagnoses and treatment of COVID-19
Gulam Rabbani, Saeyoung Nate Ahn
International Journal of Biological Macromolecules (2021) Vol. 193, pp. 948-955
Open Access | Times Cited: 115
COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes
Daniele Focosi, Massimo Franchini, Liise-anne Pirofski, et al.
Clinical Microbiology Reviews (2022) Vol. 35, Iss. 3
Open Access | Times Cited: 91
Therapeutics for COVID-19
Sima S. Toussi, Jennifer Hammond, Brian S. Gerstenberger, et al.
Nature Microbiology (2023) Vol. 8, Iss. 5, pp. 771-786
Open Access | Times Cited: 72
Extracellular vesicles mediate antibody-resistant transmission of SARS-CoV-2
Bingqing Xia, Xiaoyan Pan, Rong‐Hua Luo, et al.
Cell Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 48
SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic
Ali A. Rabaan, Shamsah H. Al-Ahmed, Ranjit Sah, et al.
Annals of Clinical Microbiology and Antimicrobials (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 136
Immunobiology and immunotherapy of COVID‐19: A clinically updated overview
Abdolreza Esmaeilzadeh, Reza Elahi
Journal of Cellular Physiology (2020) Vol. 236, Iss. 4, pp. 2519-2543
Open Access | Times Cited: 89
Clinical, laboratory, and temporal predictors of neutralizing antibodies against SARS-CoV-2 among COVID-19 convalescent plasma donor candidates
Jim Boonyaratanakornkit, Chihiro Morishima, Stacy Selke, et al.
Journal of Clinical Investigation (2020) Vol. 131, Iss. 3
Open Access | Times Cited: 82
Mechanisms of fungal dissemination
Ashley B. Strickland, Meiqing Shi
Cellular and Molecular Life Sciences (2021) Vol. 78, Iss. 7, pp. 3219-3238
Open Access | Times Cited: 82
A review on potential of natural products in the management of COVID-19
Rudra Chakravarti, Rajveer Singh, Arijit Ghosh, et al.
RSC Advances (2021) Vol. 11, Iss. 27, pp. 16711-16735
Open Access | Times Cited: 79
SARS-CoV-2 neutralizing antibodies in patients with varying severity of acute COVID-19 illness
Chandima Jeewandara, Deshni Jayathilaka, Laksiri Gomes, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 65
An updated overview of recent advances, challenges, and clinical considerations of IL-6 signaling blockade in severe coronavirus disease 2019 (COVID-19)
Reza Elahi, Parsa Karami, Amir Hossein Heidary, et al.
International Immunopharmacology (2022) Vol. 105, pp. 108536-108536
Open Access | Times Cited: 45
Emerging and reemerging infectious diseases: global trends and new strategies for their prevention and control
Shen Wang, Wujian Li, Zhenshan Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 10
Viral infection neutralization tests: A focus on severe acute respiratory syndrome‐coronavirus‐2 with implications for convalescent plasma therapy
Daniele Focosi, Fabrizio Maggi, Paola Mazzetti, et al.
Reviews in Medical Virology (2020) Vol. 31, Iss. 2
Open Access | Times Cited: 59
Pathogenesis‐directed therapy of 2019 novel coronavirus disease
Charles W. Stratton, Yi‐Wei Tang, Hongzhou Lu
Journal of Medical Virology (2020) Vol. 93, Iss. 3, pp. 1320-1342
Open Access | Times Cited: 51
Integrative overview of antibodies against SARS-CoV-2 and their possible applications in COVID-19 prophylaxis and treatment
Norma A. Valdez‐Cruz, Enrique García‐Hernández, Clara Espitia, et al.
Microbial Cell Factories (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 48
Current strategies to determine antifungal and antimicrobial activity of natural compounds
Eva Sanchez Armengol, Melisa Harmanci, Flavia Laffleur
Microbiological Research (2021) Vol. 252, pp. 126867-126867
Open Access | Times Cited: 46
Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants
William R. Strohl, Zhiqiang Ku, Zhiqiang An, et al.
BioDrugs (2022) Vol. 36, Iss. 3, pp. 231-323
Open Access | Times Cited: 32
Convalescent plasma (hyperimmune immunoglobulin) for COVID-19 management: An update
Vivek P. Chavda, Rajashri Bezbaruah, Sheetal Dolia, et al.
Process Biochemistry (2023) Vol. 127, pp. 66-81
Open Access | Times Cited: 18
Nano-Biomimetic Drug Delivery Vehicles: Potential Approaches for COVID-19 Treatment
Bwalya A. Witika, Pedzisai A. Makoni, Larry L Mweetwa, et al.
Molecules (2020) Vol. 25, Iss. 24, pp. 5952-5952
Open Access | Times Cited: 45
Plasma cell-free DNA promise monitoring and tissue injury assessment of COVID-19
Xin Jin, Yanqun Wang, Jinjin Xu, et al.
Molecular Genetics and Genomics (2023) Vol. 298, Iss. 4, pp. 823-836
Open Access | Times Cited: 16
Therapeutic plasma exchange followed by convalescent plasma transfusion in critical COVID-19—An exploratory study
Vinod Jaiswal, Prashant Nasa, May Raouf, et al.
International Journal of Infectious Diseases (2020) Vol. 102, pp. 332-334
Open Access | Times Cited: 36
Characterization of neutralizing versus binding antibodies and memory B cells in COVID-19 recovered individuals from India
Kaustuv Nayak, Kamalvishnu Gottimukkala, Sanjeev Kumar, et al.
Virology (2021) Vol. 558, pp. 13-21
Open Access | Times Cited: 31
Chemotherapy vs. Immunotherapy in combating nCOVID19: An update
Abhigyan Choudhury, Gargi Mukherjee, Suprabhat Mukherjee
Human Immunology (2021) Vol. 82, Iss. 9, pp. 649-658
Open Access | Times Cited: 30
Page 1 - Next Page

Scroll to top